2023
DOI: 10.1016/j.biopha.2023.114334
|View full text |Cite
|
Sign up to set email alerts
|

A second-generation artificial intelligence-based therapeutic regimen improves diuretic resistance in heart failure: Results of a feasibility open-labeled clinical trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7
1

Relationship

5
3

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 49 publications
0
5
0
Order By: Relevance
“…A CDP-based second-generation AI system was shown to overcome diuretic tolerance in patients with heart failure, improving the clinical and laboratory measures. 47 Similarly, improvement was shown in patients with immune-mediated disease and patients with chronic pain with loss of effects of their chronic therapies. 48 Monitoring and follow-up model based on co-piloting.…”
Section: An Improved Diagnosis Model Based On Co-pilotingmentioning
confidence: 94%
“…A CDP-based second-generation AI system was shown to overcome diuretic tolerance in patients with heart failure, improving the clinical and laboratory measures. 47 Similarly, improvement was shown in patients with immune-mediated disease and patients with chronic pain with loss of effects of their chronic therapies. 48 Monitoring and follow-up model based on co-piloting.…”
Section: An Improved Diagnosis Model Based On Co-pilotingmentioning
confidence: 94%
“…By introducing personalized variability in dosing and administration times into treatments, CDP-based AI platforms overcome drug tolerance [274][275][276][279][280][281][282][283][284][285][286][287][288][289][290][291][292][293][294][295][296][297][298]. By quantifying variability signatures, these algorithms aim to overcome or prevent tolerance to chronic medications [18,126,[279][280][281][282][283][284][285][286][287][288][289][290][291][292][293][294][295][296][299][300][301][302][303]…”
Section: Cdp-based Platform To Overcome Drug Tolerancementioning
confidence: 99%
“…By introducing personalized variability in dosing and administration times into treatments, CDP-based AI platforms overcome drug tolerance [ 274 , 275 , 276 , 279 , 280 , 281 , 282 , 283 , 284 , 285 , 286 , 287 , 288 , 289 , 290 , 291 , 292 , 293 , 294 , 295 , 296 , 297 , 298 ]. By quantifying variability signatures, these algorithms aim to overcome or prevent tolerance to chronic medications [ 18 , 126 , 279 , 280 , 281 , 282 , 283 , 284 , 285 , 286 , 287 , 288 , 289 , 290 , 291 , 292 , 293 , 294 , 295 , 296 , 299 , 300 , 301 , 302 , 303 , 304 , 305 ,…”
Section: Introductionmentioning
confidence: 99%
“…These systems improved clinical and laboratory measures in patients with chronic heart failure, reducing emergency room admissions and hospitalizations [ 268 ]. Similar results were shown for patients with multiple sclerosis and those suffering from chronic pain [ 238 ].…”
Section: Digital Health Challenges Can Be Overcome By Using Cdp-based...mentioning
confidence: 99%